Skip header and navigation

3 records – page 1 of 1.

Document Type
Table
Review Code
EOC210901 RR Table
Question Submitted
September 21, 2021
Date Completed
September 30, 2021
Status
3. Completed
Research Team
EOC
Document Type
Table
Review Code
EOC210901 RR Table
Question Submitted
September 21, 2021
Date Completed
September 30, 2021
Status
3. Completed
Research Team
EOC
Category
Infection Prevention and Control
Subject
Face Masks
Pediatrics
Public Health
Schools
Population
All Pediatrics
All adults
Clinical Setting
Public Health
Priority Level
Level 4 Three weeks (21 days)
Cite As
Badea, A; Groot, G; Muhajarine, N; Howell-Spooner, B; Young, C. What is the evidence for the effectiveness of universal mask use in the pediatric population? 2021 Sep 30, Document no.: EOC210901 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2021. (CESTtable).
Related Documents
Documents

EOC210901 RR Table

Download File
Less detail
Document Type
Rapid Review
Review Code
EOC210901 RR
Question Submitted
September 21, 2021
Date Completed
September 30, 2021
Status
3. Completed
Research Team
EOC
Document Type
Rapid Review
Review Code
EOC210901 RR
Question Submitted
September 21, 2021
Date Completed
September 30, 2021
Status
3. Completed
Research Team
EOC
Key Findings
September 30, 2021
Studies conducted before mass vaccination campaigns began have reported proper and consistent facemasking by students and staff in school settings are associated with reduced incidence of school-associated transmission or seropositivity.
Fewer studies have reported efficacy of facemasking in the post-mass vaccination period in school settings. The studies available report, however, school-associated transmission were lower, less than 1% secondary attack rate in schools.
Studies of school-associated COVID-19 cases find community exposure to SARS-CoV-2 and/or noncompliance with multiple mitigation measures (e.g. facemask policies, distancing, non-isolation, etc) are key factors of clusters and outbreaks in children.
Category
Infection Prevention and Control
Subject
Face Masks
Public Health
Schools
Pediatrics
Population
All Pediatrics
All adults
Clinical Setting
Public Health
Priority Level
Level 4 Three weeks (21 days)
Cite As
Badea, A; Groot, G; Muhajarine, N; Howell-Spooner, B; Young, C. What is the evidence for the effectiveness of universal mask use in the pediatric population? 2021 Sep 30, Document no.: EOC210901 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2021. 14 p. (CEST rapid review report).
Related Documents
Documents
Less detail
Document Type
Rapid Review
Review Code
PH030801 RR
Question Submitted
March 8, 2021
Date Completed
March 30, 2021
Status
6. Cancelled
Research Team
Public Health
Document Type
Rapid Review
Review Code
PH030801 RR
Question Submitted
March 8, 2021
Date Completed
March 30, 2021
Status
6. Cancelled
Research Team
Public Health
Key Findings
Pediatric cases of COVID-19 constitute between 1% to 10% of all confirmed cases of COVID-19; variation exists by jurisdiction.
Few case reports exist of confirmed child-to-other transmission. Contact tracing studies suggest that children are unlikely to be transmitters of the disease. Households are the most likely environments for transmission.
A recent large South Korean contact tracing study however (in pre-print) found that household COVID-19 transmission rates for children age 10-19 were significantly higher than in adults; transmission rates for children age 0-9 were relatively low.
AUGUST 7th, 2020 UPDATE: No new studies examining secondary attack rates of pediatric index cases were found. Studies continue to suggest low transmission from pediatric cases, and high proportion of pediatric cases being asymptomatic to mildly symptomatic.
MARCH 9th, 2021 UPDATE: Variants of Concerns are an emerging threat, but literature on pediatric prevalence and transmissibility is sparse. The British variant seems more transmissible (secondary attack rate higher) but follows the same age-related distribution of cases seen earlier in the pandemic.
Category
Epidemiology
Infection Prevention and Control
Subject
Vaccines
Variants
Pediatrics
Transmission
Schools
Population
All Pediatrics
Clinical Setting
Public Health
Priority Level
Level 2 One week (7 days)
Cite As
Sulaiman, F; Coomaran, V; Muhajarine, N; Dalidowicz, M; Miller, L. What are the effects of the new COVID variants on transmission and school reopenings in pediatric populations? 2021 Mar 30; Document no.: PH030801 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 14p. (CEST rapid review report)
Similar Reviews
EOC072102-01 ESR
EOC070201v2-01 ESR
EOC081201-01 ESR
Related Documents
Documents
Less detail